新聞說: 「..僅用了不到 2 個小時，便完成了人類科學家平均耗時近 4 個月（約 900 小時）的工作量，甚至自主發現了治療致盲眼疾「乾性年齡相關性黃斑部病變（dAMD）」的潛在老藥新用候選方案，為 AI 驅動的科學探索樹立了全新的里程碑。..」
以及Nature: 「 ..Robin proposed enhancing retinal pigment epithelium phagocytosis as a therapeutic strategy, and identified and confirmed in vitro efficacy for ripasudil and KL001. Ripasudil is a clinically-used Rho kinase (ROCK) inhibitor that has never previously been proposed for treating dAMD… 」
………
Glory to the Sky 